BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Change in Account Payables (2018 - 2019)

Updated

BioXcel Therapeutics' Change in Account Payables came in at $4,000 for Q1 2019, down 69.2% from $13,000 a year earlier.

Analysis

BioXcel Therapeutics (BTAIQ) Change in Account Payables (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 18.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 4,000.00
Mar 31, 2018 13,000.00
API Access

BioXcel Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY